130 related articles for article (PubMed ID: 8621218)
1. Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer.
Yin BW; Finstad CL; Kitamura K; Federici MG; Welshinger M; Kudryashov V; Hoskins WJ; Welt S; Lloyd KO
Int J Cancer; 1996 Feb; 65(4):406-12. PubMed ID: 8621218
[TBL] [Abstract][Full Text] [Related]
2. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
[TBL] [Abstract][Full Text] [Related]
3. Lex and Ley antigen expression in human pancreatic cancer.
Kim YS; Itzkowitz SH; Yuan M; Chung Y; Satake K; Umeyama K; Hakomori S
Cancer Res; 1988 Jan; 48(2):475-82. PubMed ID: 3335015
[TBL] [Abstract][Full Text] [Related]
4. Lewis Y antigen expression in hepatocellular carcinoma. An immunohistochemical study.
Wakabayashi M; Shiro T; Seki T; Nakagawa T; Itoh T; Imamura M; Shiozaki Y; Inoue K; Okamura A
Cancer; 1995 Jun; 75(12):2827-35. PubMed ID: 7539714
[TBL] [Abstract][Full Text] [Related]
5. Activation-dependent expression of the blood group-related lewis Y antigen on peripheral blood granulocytes.
Dettke M; Pálfi G; Loibner H
J Leukoc Biol; 2000 Oct; 68(4):511-4. PubMed ID: 11037972
[TBL] [Abstract][Full Text] [Related]
6. Expression of LeY and extended LeY blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues.
Kim YS; Yuan M; Itzkowitz SH; Sun QB; Kaizu T; Palekar A; Trump BF; Hakomori S
Cancer Res; 1986 Nov; 46(11):5985-92. PubMed ID: 2428490
[TBL] [Abstract][Full Text] [Related]
7. Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guided therapy.
Chauhan SC; Vinayek N; Maher DM; Bell MC; Dunham KA; Koch MD; Lio Y; Jaggi M
J Histochem Cytochem; 2007 Aug; 55(8):867-75. PubMed ID: 17478446
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention.
Rodríguez-Burford C; Barnes MN; Berry W; Partridge EE; Grizzle WE
Gynecol Oncol; 2001 Jun; 81(3):373-9. PubMed ID: 11371125
[TBL] [Abstract][Full Text] [Related]
9. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
10. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene.
Dahiya R; Kwak KS; Byrd JC; Ho S; Yoon WH; Kim YS
Cancer Res; 1993 Mar; 53(6):1437-43. PubMed ID: 8443822
[TBL] [Abstract][Full Text] [Related]
11. Stage-specific expression of SSEA-1-related antigens in the developing lung of human embryos and its relation to the distribution of these antigens in lung cancers.
Miyake M; Zenita K; Tanaka O; Okada Y; Kannagi R
Cancer Res; 1988 Dec; 48(24 Pt 1):7150-8. PubMed ID: 2903794
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides.
Ioannides CG; Fisk B; Jerome KR; Irimura T; Wharton JT; Finn OJ
J Immunol; 1993 Oct; 151(7):3693-703. PubMed ID: 7690810
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule.
Lloyd KO; Yin BW; Kudryashov V
Int J Cancer; 1997 May; 71(5):842-50. PubMed ID: 9180155
[TBL] [Abstract][Full Text] [Related]
14. Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC
Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277
[TBL] [Abstract][Full Text] [Related]
15. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.
Sakamoto J; Furukawa K; Cordon-Cardo C; Yin BW; Rettig WJ; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1986 Mar; 46(3):1553-61. PubMed ID: 3510728
[TBL] [Abstract][Full Text] [Related]
16. Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines.
Kloudová K; Hromádková H; Partlová S; Brtnický T; Rob L; Bartůňková J; Hensler M; Halaška MJ; Špíšek R; Fialová A
Oncotarget; 2016 Jul; 7(29):46120-46126. PubMed ID: 27323861
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
[TBL] [Abstract][Full Text] [Related]
18. The role of anti-LeY antibody in the downregulation of MAPKs/COX-2 pathway in gastric cancer.
Aziz F; Qiu Y
Curr Drug Targets; 2014 Apr; 15(4):469-76. PubMed ID: 24533777
[TBL] [Abstract][Full Text] [Related]
19. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases.
Matsushita Y; Cleary KR; Ota DM; Hoff SD; Irimura T
Lab Invest; 1990 Dec; 63(6):780-91. PubMed ID: 1979361
[TBL] [Abstract][Full Text] [Related]
20. Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence-Coupled Biopanning Platform.
Frietze KM; Roden RB; Lee JH; Shi Y; Peabody DS; Chackerian B
Cancer Immunol Res; 2016 Feb; 4(2):157-64. PubMed ID: 26589767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
